Other Publications
 

Document Type

Article

Publication Date

2017

Abstract

The Broad Institute's recent licensing of its gene editing patent portfolio demonstrates how licenses can be used to restrict controversial applications of emerging technologies while society deliberates their implications.

Comments

35 Nature Biotechnology 22 (2017)

Share

COinS